Oxis Biotech Announces U.S. Patent and Trademark Office Notification of Patent Issuance for Oxis-4235 as Treatment for Multiple Myeloma February 21, 2017
Oxis Biotech Announces Enrollment of 2 New Patients in FDA Clinical Trial of Promising Cancer Drug OXS-1550 January 17, 2017
